Search research articles
Contact Us
Filters
Showing results (101-110 of 223) with videos related to
Page
of 23
Sort By:
Disease Markers
|
January 11, 2019
Grading of Neuroendocrine Carcinomas: Correlation of <sup>68</sup>Ga-PET/CT Scan with Tissue Biomarkers
Chiara Liverani, Alberto Bongiovanni, Laura Mercatali, et al.
Bone
|
November 29, 2020
Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis
Chiara Spadazzi, Laura Mercatali, Mark Esposito, et al.
The Lancet. Oncology
|
September 3, 2013
What can we learn from the ZOOM trial?--Authors' reply
Dino Amadori, Laura Mercatali, Oriana Nanni, et al.
Frontiers in Immunology
|
July 10, 2024
Clinical and translational implications of immunotherapy in sarcomas
Federica Recine, Silvia Vanni, Alberto Bongiovanni, et al.
Scientific Reports
|
June 11, 2026
Circulating IGF2BP3 enables risk stratification and predicts treatment response in Ewing sarcoma
Caterina Mancarella, Alessandra De Feo, Irene Dirignani, et al.
Endocrine Pathology
|
January 7, 2021
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms
Chiara Liverani, Alberto Bongiovanni, Laura Mercatali, et al.
Biochimica Et Biophysica Acta
|
February 11, 2014
Targeting bone metastatic cancer: Role of the mTOR pathway
Francesco Bertoldo, Franco Silvestris, Toni Ibrahim, et al.
Breast Cancer Research and Treatment
|
May 28, 2015
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer
Andrea Rocca, Alberto Farolfi, Roberta Maltoni, et al.
Frontiers in Oncology
|
April 23, 2020
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
Alberto Bongiovanni, Chiara Liverani, Federica Recine, et al.
Cancers
|
November 14, 2023
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
Enrico Lucarelli, Alessandro De Vita, Chiara Bellotti, et al.
Page
of 23
Search research articles
Search
Showing results (101-110 of 223) with videos related to
Sort By:
Page
of 23
Disease Markers
|
January 11, 2019
Grading of Neuroendocrine Carcinomas: Correlation of <sup>68</sup>Ga-PET/CT Scan with Tissue Biomarkers
Chiara Liverani, Alberto Bongiovanni, Laura Mercatali, et al.
Bone
|
November 29, 2020
Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis
Chiara Spadazzi, Laura Mercatali, Mark Esposito, et al.
The Lancet. Oncology
|
September 3, 2013
What can we learn from the ZOOM trial?--Authors' reply
Dino Amadori, Laura Mercatali, Oriana Nanni, et al.
Frontiers in Immunology
|
July 10, 2024
Clinical and translational implications of immunotherapy in sarcomas
Federica Recine, Silvia Vanni, Alberto Bongiovanni, et al.
Scientific Reports
|
June 11, 2026
Circulating IGF2BP3 enables risk stratification and predicts treatment response in Ewing sarcoma
Caterina Mancarella, Alessandra De Feo, Irene Dirignani, et al.
Endocrine Pathology
|
January 7, 2021
Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms
Chiara Liverani, Alberto Bongiovanni, Laura Mercatali, et al.
Biochimica Et Biophysica Acta
|
February 11, 2014
Targeting bone metastatic cancer: Role of the mTOR pathway
Francesco Bertoldo, Franco Silvestris, Toni Ibrahim, et al.
Breast Cancer Research and Treatment
|
May 28, 2015
Efficacy of endocrine therapy in relation to progesterone receptor and Ki67 expression in advanced breast cancer
Andrea Rocca, Alberto Farolfi, Roberta Maltoni, et al.
Frontiers in Oncology
|
April 23, 2020
Phase-II Trials of Pazopanib in Metastatic Neuroendocrine Neoplasia (mNEN): A Systematic Review and Meta-Analysis
Alberto Bongiovanni, Chiara Liverani, Federica Recine, et al.
Cancers
|
November 14, 2023
Modeling Myxofibrosarcoma: Where Do We Stand and What Is Missing?
Enrico Lucarelli, Alessandro De Vita, Chiara Bellotti, et al.
Page
of 23